{
    "organizations": [],
    "uuid": "e52a2b4b35cbf817f057240ee48ce455bd0c3b38",
    "author": "",
    "url": "https://www.reuters.com/article/us-loxo-oncology-partnership-illumina/loxo-and-illumina-in-partnership-over-diagnostic-for-cancer-drug-idUSKBN1HH1QN",
    "ord_in_thread": 0,
    "title": "Loxo and Illumina in partnership over diagnostic for cancer drug",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "(Reuters) - Loxo Oncology ( LOXO.O ) is partnering with genetic testing company Illumina Inc ( ILMN.O ) to use Illumina’s diagnostic tool alongside larotrectinib, the drug developer’s potential blockbuster drug, the companies said on Tuesday.\nThe partnership will seek approval for a version of the Illumina’s test, TruSight Tumor 170, as a companion diagnostic for Loxo’s larotrectinib and another one of Loxo’s experimental cancer drugs, across tumor types.\nReporting by Manas Mishra in Bengaluru; Editing by Shailesh Kuber\n ",
    "published": "2018-04-10T14:44:00.000+03:00",
    "crawled": "2018-04-10T15:06:56.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "reuters",
        "loxo",
        "oncology",
        "partnering",
        "genetic",
        "testing",
        "company",
        "illumina",
        "inc",
        "use",
        "illumina",
        "diagnostic",
        "tool",
        "alongside",
        "larotrectinib",
        "drug",
        "developer",
        "potential",
        "blockbuster",
        "drug",
        "company",
        "said",
        "tuesday",
        "partnership",
        "seek",
        "approval",
        "version",
        "illumina",
        "test",
        "trusight",
        "tumor",
        "companion",
        "diagnostic",
        "loxo",
        "larotrectinib",
        "another",
        "one",
        "loxo",
        "experimental",
        "cancer",
        "drug",
        "across",
        "tumor",
        "type",
        "reporting",
        "manas",
        "mishra",
        "bengaluru",
        "editing",
        "shailesh",
        "kuber"
    ]
}